2 completed, 1 recruiting, 1 unknown. 4 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 2, Recruiting 1, Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Reduced Intensity Conditioning: new trials by email Literature Review of Reduced Intensity Conditioning trials Research Report on Reduced Intensity Conditioning
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ruxolitinib With Azacitidine Maintenance for the Treatment of Patients With Acute Myeloid Leukemia Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation Allogeneic Hematopoietic Stem Cell Transplantation, Azacitidine, Biospecimen Collection - Acute Myeloid Leukemia | Phase 1 | Recruiting | OHSU Knight Cancer Institute | 40 | 2026-04-21 | 2026-10-05 |
| Haploidentical Hematopoietic Stem Cell Transplantation peripheral blood stem cell graft that are CD34+ selected - Sickle Cell-thalassemia Disease, Thalassemia | Phase 1 | Completed | Catherine Bollard | 7 | 2015-01-01 | 2024-12-19 |
| Immunotherapy Following Reduced Intensity Conditioning and Allogeneic Stem Cell Transplant for Poor Risk CD30+ Hodgkin Lymphoma Patients Brentuximab Vedotin, Allogeneic Stem Cell Transplantation, Reduced Intensity Conditioning - Hodgkin Lymphoma | Phase 1 / Phase 2 | Unknown | New York Medical College | 20 | 2014-03-01 | 2022-10-27 |
| Reduced Intensity Conditioning for Umbilical Cord Blood Transplant in Pediatric Patients With Non-Malignant Disorders Unrelated Umbilical Cord Blood Transplant, Reduced Intensity Conditioning - Non Malignant Disorders, Immunodeficiencies | Phase 1 | Completed | Duke University | 22 | 2008-10-01 | 2014-08-13 |
Thalassemia (2) · Anemia, Diamond-Blackfan (1) · Hemoglobinopathies (1) · Hodgkin Disease (1) · Immunologic Deficiency Syndromes (1) · Leukemia, Myeloid, Acute (1) · Lysosomal Storage Diseases (1) · Metabolism, Inborn Errors (1) · Mucopolysaccharidosis I (1) · Mucopolysaccharidosis II (1) · Severe Combined Immunodeficiency (1)
Catherine Bollard (1) · Duke University (1) · New York Medical College (1) · OHSU Knight Cancer Institute (1)
United States (4)
Jennifer N Saultz (1) · Mitchell Cairo, MD (1) · Suhag Parikh, MD (1)